Data through FY2026 Q3 (Jun 30, 2026)
Travere Therapeutics, Inc.
Company profile for Travere Therapeutics, Inc. covers 8 filings across the reporting window. FY2026 certified median offer: $179,192.
- FY2026 certified median
- $179,192
- Total filings
- 8
- FY2026 25th–75th percentile
- $157,571–$200,814
- Top job title
- Senior Manager, Commercial Regulatory Affairs
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 3 | $120,000 | $120,000 | $120,000 |
| FY2025 | 3 | $136,136 | $128,068 | $138,466 |
| FY2026 (Q1–Q3) | 2 | $179,192 | $157,571 | $200,814 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Senior Manager, Commercial Regulatory Affairs2 filings
- Associate Director, Pharmacovigilance1 filings
- Manager, HRIS Operations1 filings
- Principal Statistical Programmer1 filings
- Senior Manager, Commercial Analytics1 filings
- Senior Manager, Quality Assurance1 filings
- Senior Medical Director, Nephrology1 filings